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Ethanol-induced folate deﬁciency is due to eﬀects of ethanol on folate metabolism and absorption. We have already shown by
using diﬀerent methods that ethanol interferes with reabsorption of folate from the proximal tubule. In this study, we have used
the folate analogue, the ﬂuorescein methotrexate (FL-MTX), in order to evaluate eﬀects of ethanol on FL-MTX uptake by the
human proximal tubular (HPT) cells by using a confocal microscope and ﬂuoroskan microplate reader. Since endothelins (ETs)
play a major role in a number of diseases and also in the damage induced by a variety of chemicals, we have used endothelin-
B (ET-B) and protein kinase-C (PKC) inhibitors to evaluate the role of endothelin in ethanol-mediated FL-MTX uptake by
using ﬂuoroskan microplate reader. Confocal microscope and ﬂuoroskan studies reveal that cellular absorption of FL-MTX is
concentration-dependent. Moreover, ethanol concentration has an impact on FL-MTX uptake. Fluoroskan studies reveal that the
ethanol-induced decrease in FL-MTX uptake is reversed by adding the ET-B receptor antagonist (RES-701-1) or PKC-selective
inhibitor (BIM). Thus, we can conclude that ethanol may act via ET and ET in turn may act via ET-B receptor and the PKC
signaling pathway to impair FL-MTX transport.
Copyright © 2009 S. J. Gowder and K. E. McMartin. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Folate is a water-soluble vitamin that occurs in natural food
sources as reduced methylated or formylated tetrahydrofo-
late. Folic acid is a synthetic analogue with no specialized
metabolic activity [1]. Folate is essential for cellular prolif-
eration and tissue regeneration. As mammalian cells cannot
synthesize folates de novo, tightly regulated cellular uptake
processes have evolved to sustain suﬃcient levels of intra-
cellular tetrahydrofolate cofactors to support biosynthesis of
purines, pyrimidines, and some amino acids [2]. Folate has
emergedasakeynutrientforoptimizinghealthandimpaired
folate status has been found as a risk factor for cancer,
cardiovascular disease, and neurocognitive disorders [3].
Plasma folate seems to be a suitable marker for assessment
of folate status for use in large-scale epidemiological studies
[4].
Renal tubular reabsorption of ﬁltered folate is essential
for the conservation and normal homeostasis of this impor-
tant vitamin [5]. Although reabsorption across the apical
(AP) membrane of the renal proximal tubule cell plays a vital
role in the conservation of plasma 5-methyltetrahydrofolate,
basolateral (BL) membrane-directed secretory pathways may
alsobeimportantinregulatingtheurinaryexcretionoffolate
[6]. The reduced folate carrier (RFC) plays a critical role
in the cellular uptake of folates. However, a little is known
regarding the mechanism used to transport substrates or the
tertiary structure of the protein [7].
Epidemiologic studies on humans and experimental
studies on animals show that alcohol causes cancer through
diﬀerent mechanisms, including through mutagenesis by
acetaldehyde, through perturbation of estrogen metabolism
and response, and through inducing oxidative damage
and/or by aﬀecting folate and one-carbon metabolism2 Advances in Pharmacological Sciences
pathways [8]. Ethanol-induced folate deﬁciency is due to
the eﬀects of ethanol on folate metabolism and absorption.
We have already shown by using diﬀerent methods that
ethanol interferes with the reabsorption of folate from the
proximaltubule.Acuteethanolingestionbyhumanalcoholic
subjects produces a marked decrease in serum folate levels
in 16 hours [9]. In rats, acute doses of ethanol produce a
marked increase in urinary folate excretion which precedes
a decrease in plasma folate levels [10]. Studies on acute
ethanol in cultured human proximal tubular (HPT) cells
have shown the inhibition of reabsorptive transport of 5-
methyltetrahydrofolate [11].
In this study, we used the folate analogue, the ﬂuorescein
methotrexate (FL-MTX), as a model compound of our study
to evaluate the eﬀect of ethanol on FL-MTX uptake by
the HPT cells by using confocal microscope and ﬂuoroskan
microplate reader. Fluorescein methotrexate (F-MTX), a
ﬂuorescent derivative of MTX, was synthesized by coupling
the carboxyl of the glutamate moiety of MTX through a
diaminopentane spacer to ﬂuorescein isothiocyanate [12].
We used our HPT cells to elucidate the mechanism of FL-
MTX since these cells provide a good model to understand
the mechanism of transport studies. Endothelins (ETs) are
polypeptide hormones that are potent vasoconstrictors [13].
In the kidney, endothelin plays a major role in controlling
water and sodium excretion and acid base balance and it is
participated in acute and chronic renal failure [14]. Since
ETs play a major role in a number of diseases and also in the
damage induced by a variety of chemicals [15], we have used
Endothelin-B (ET-B) and protein kinase-C (PKC) inhibitors
to evaluate the role of endothelin in ethanol-mediated FL-
MTX uptake by using ﬂuoroskan microplate reader.
2.MaterialsandMethods
2.1. Materials. FL-MTX, BIM (Bisindolylmaleimide I, PKC-
Selective Inhibitor) were purchased from Molecular Probes
(Eugene, Ore, USA) and RES-701-1 (ET-B receptor antag-
onist) was purchased from American Peptide Company
(Sunnyvale, Calif, USA). We purchased all other chemicals
u s e di nt h i ss t u d yf r o mS i g m aC h e m i c a lC o( S t .L o u i s ,M o ,
USA), Collaborative Biomedical Research (Bedford, Mass,
USA) and GIBCO (Grand Island, NY, USA).
2.2. Cell Culture. HPT cells from normal human kidney
cortex tissue (from kidneys unable to be used in transplan-
tation) were isolated by the enzyme dissociation method
using a DNAase-collagenase mixture as described previously
[16]. Isolated cells were regularly cultured on collagen-
coated 75cm2 ﬂasks (Costar, Cambridge, Mass, USA) in a
serum-free mixture of Dulbecco’s modiﬁed Eagle’s medium-
Ham’s F-12 medium (50 : 50 by volume) with the following
additions per L: selenium (5μg), insulin (5mg), transferrin
(5μg), hydrocortisone (36μg), epidermal growth factor
(10μg), triiodothyronine (4ng), and 2mmol glutamine.
When the HPT cells were grown to conﬂuency in tissue
culture ﬂasks, the cells were subcultured onto 24-well plates
(Costar, Cambridge, Mass, USA). We used the cells when
they attained conﬂuency for this study.
2.3. Confocal Microscopy. HPT cells in the 24 well plates
were washed twice with room temperature buﬀer (PBS). The
cells were treated with (a) 1.5mL of PBS with 0.5,1,2, and
4μM of FL-MTX and (b) 4μMo fF L - M T Xa n dd i ﬀerent
concentrations (0,500 and 750mg/dL) of ethanol for 30–
45minutes of incubation at 37
◦C. The cells were subjected
to confocal microscopy.
The cells in the 24 well plates were directly observed
under Bio Rad Radiance 2000 Confocal microscope and
viewed through a 40X CF inﬁnity plan ﬂuor objective.
Excitation was provided by the 488nm line of an argon
laser. A 515/30nm ﬁlter and a 545/40nm dichroic ﬁlter
were used. The trapped signal was sent inside the Photo
Multiplier Tubes which capture light using total internal
reﬂection. A few cells in the wells were selected and the
images were viewed. Bio-Rad’s Lasersharp-I allows 32-bit
image acquisition, display and 3D volume rendering, and
image analysis.
2.4. Fluoroskan Microplate Reader. HPT cells in the 24 well
plates were washed twice with room temperature pH 7.4
incubation buﬀer (20mM HEPES, pH 7.4, containing NaCl,
KCl, CaCl2,M g C l 2, D-glucose, and NaHCO3) and then
treated with (a) 1.5mL of the above incubation buﬀer
containing 1, 2, 4, 8, and 16μMF L - M T X ,( b )1 . 5 m Lo f
incubation buﬀer containing 10μM FL-MTX and diﬀerent
concentrations (0, 100, 200, 300, 400, and 500mg/dL) of
ethanol, and (c) 1.5mL of incubation buﬀer containing
10μM FL-MTX, 500mg/dL ethanol and 10μME T - Br e c e p -
torantagonist(RES-701-1)or2.5μMPKCselectiveinhibitor
(BIM), respectively, for 2hours of incubation at 37
◦C. The
cells were washed with incubation buﬀer and then the
ﬂuorescence intensity was read in ﬂuoroskan reader with an
appropriate ﬁlter.
2.5. Statistical Analysis. Data are expressed as mean ± SEM
(n = 5). All statistical analysis was carried out using SAS 9.1
(SAS Institute, Cary, NC, USA). One way analysis of variance
withDuncan’s multiple range testswasperformedto identify
the statistical signiﬁcance. A P- value of less than .05 was
considered statistically signiﬁcant.
3. Results
Confocal microscopic (Figure 1) and ﬂuoroskan studies
(Figure 2) revealed that cellular absorption of FL-MTX
was concentration-dependent. The cellular absorption of
diﬀerent concentrations of FL-MTX uptake is signiﬁcantly
diﬀerent (P<. 001) (Figure 2).The cellular ﬂuorescence
w a sm o r ei nt h ec e l l st r e a t e dw i t h4μMo fF L - M T Xw h e n
compared with the cells treated with less concentrations of
FL-MTX (Figure 1). When there was an increase of FL-MTX
concentration, there was an increase of FL-MTX uptake.
Thus, the uptake of FL-MTX was found to depend on
its extracellular concentration and conforms to Michaelis-
Menten kinetics. That is, initial velocities of transport of FL-
MTX increased in proportion to its concentrations.
Moreover, ethanol concentration was found to have an
impact on FL-MTX uptake. When there was an increaseAdvances in Pharmacological Sciences 3
HPT-cells treated with
4 μM of FL-MTX 
(a)
HPT-cells treated with
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Figure 1: Confocal images of FL-MTX uptake by HPT cells in 24
well plates. Cellular ﬂuorescence was more when the cells treated
with 4μM FL-MTX and it was gradually decreasing when the cells
were treated with 2μM, 1μM, and 0.5μM FL-MTX. Thus, FL-MTX
uptake was directly proportional to its concentrations.
in ethanol concentration, there was a decrease in FL-MTX
uptake (Figures 3 and 4). For confocal studies, we used 0,
500, and 750mg/dL ethanol. From the confocal images, we
can observe that the cellular ﬂuorescence of FL-MTX of the
cells treated with ethanol at the concentration of 500mg/dL
w a sl e s sw h e nc o m p a r e dw i t hc o n t r o l sa n dm o r ew h e n
compared with the cells treated with 750mg/dL (Figure 3).
For ﬂuoroskan studies, we used various concentrations of
ethanol 0, 100, 200, 300, 400, and 500mg/dL and observed
that the FL-MTX uptake was gradually decreased when
the concentrations of ethanol were increased and the eﬀect
of diﬀerent concentrations of ethanol on cellular uptake
of FL-MTX is signiﬁcantly diﬀerent (P<. 001), (see
Figure 4). We used 4μMa n d1 0μMF L - M T Xf o rc o n f o c a l
and ﬂuoroskan studies when used with diﬀerent concen-
trations of ethanol. We standardized these FL-MTX con-
centrations based on diﬀerent FL-MTX uptake experiments
by using confocal microscopy and ﬂuoroskan microplate
reader.
Fluoroskan studies revealed that ethanol-induced de-
crease in FL-MTX uptake was reversed and it is signiﬁcant
(P<. 001) by adding ET-B receptor antagonist (RES-701-1)
orPKCselectiveinhibitor(BIM)(Figure 5).Westandardized
from diﬀerent experiments and hence we used 500mg/dL
ethanol, 10μMF L - M T X ,1 0 μM ET-B receptor antagonist
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Figure 2: Fluoroskan studies of FL-MTX (10μM) uptake by HPT
cells in 24 well plates. FL-MTX uptake is directly proportional to its
concentrations. Data are expressed as mean ± SEM (n = 5).
(RES-701-1), or 2.5μM PKC-selective inhibitor (BIM) for
this study. From this experiment, we can suggest that ethanol
may act via ET and ET in turn may act via ET-B receptor
andPKCsignalingpathwaytoimpairFL-MTXtransport.We
standardized the concentrations of RES-710-1 and BIM in
this study based on various experiments.
4. Discussion
For folate uptake and other toxicological studies, we are
traditionally growing HPT cells, which formed a useful tool
to understand various mechanisms. HPT cells which were
f u l l yg r o w na n dc o n ﬂ u e n ti n2 4w e l lp l a t e sw e r eu s e df o r
this study. The cells form conﬂuent monolayers on plastic
as well as on porous membrane inserts and produce domes
(hemicysts) in culture were indicating retention of ion trans-
port properties and integrity of cell to cell junctions. Before
conducting the present experiment, we also characterized
these cells histochemically by using our recently developed
methods for gamma glutamyl transpeptidase (GGT) and
glucose-6-phosphatase (G-6-P) (data not shown). The cells
were positive for GGT and G-6-P. The cells, thus, retained
the membrane integrity and function like that of the
intact proximal tubule and hence we used these cells to
develop confocal and ﬂuoroskan methods to understand the
mechanism of FL-MTX uptake studies.
We developed our confocal method in such a way so as
to demonstrate the images in 24 well plates directly. When
we treated the HPT cells with diﬀerent concentrations of
FL-MTX and viewed by using the confocal microscope, we
observed that cellular uptake of FL-MTX is concentration-
dependant. Fluoroskan method also showed that cellular
uptake of FL-MTX was concentration dependant. In general,
transport on the “classical” organic anion system in renal
proximal tubule is speciﬁc and active. Assaraf et al. [17]
demonstrated that FL-MTX is accumulated in cells by
a passive diﬀusion process. Miller [18] realized that the
secretion of large organic anion, that is, FL-MTX is handled
by a separate and distinct organic anion transport system.
Masereeuw et al. [19] suggested that cellular accumulation4 Advances in Pharmacological Sciences
0 mg/dL (control)
(a)
500 mg/dL
(b)
750 mg/dL
(c)
Figure 3: Confocal images of HPT cells in 24 well plates treated with FL-MTX (4μM) and diﬀerent concentrations of ethanol (0, 500, and
750mg/dL). The images reveal that ethanol concentration has an impact on FL-MTX uptake.
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Figure 4: Fluoroskan studies of FL-MTX (10μM) uptake by
HPT cells in 24 well plates treated with diﬀerent concentrations
(0, 100, 200, 300, 400, and 500mg/dL) of ethanol. Ethanol
concentrationhasanimpactonFL-MTXuptake.Dataareexpressed
as mean ± SEM (n = 5).
of FL-MTX is a result of diﬀuse entry and it is energy-
independent. FL-MTX transport by RFC in human leukemia
cell lines and leukemia blasts was demonstrated by confocal
laser scanning microscopy [20]. Li et al. [21] observed that
the transport of FL-MTX is mediated by the reduced folate
transporter (RFC) in brush border membrane vesicles of
rat small intestine. The reduced folate carrier (RFC), a
facilitative transporter, plays a major role in the delivery of
reduced folates and antifolates into cells [22]. Thus, FL-MTX
uptake was regulated by RFC in this experiment.
It is quite clear from both the confocal and ﬂuoroskan
methods that ethanol reduced FL-MTX uptake in a con-
centration dependant manner. Since the confocal methods
were quite comparable with our ﬂuoroskan methods, we
concluded that our protocol was quite clear for both the
methods. Miller [15] observed that a few drugs impaired
FL-MTX transport with respect to their concentration.
Villanueva et al. [23] reveals that chronic ethanol exposure
decreases the absorption of folic acid by altering the expres-
sion of RFC and consequently its transport kinetics. Our
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Figure 5: Fluoroskan studies of FL-MTX (10μM) uptake by HPT
cells in 24 well plates treated with ethanol (500mg/dL), ET-
B receptor antagonist (RES-701-1) (10μM), and PKC selective
inhibitor (BIM) (2.5μM). Inhibition of FL-MTX uptake is reversed
by the addition of RES-701-1 or BIM. Data are expressed as mean
± SEM (n = 5).
previous studies indicate that ethanol directly impairs the
renal conservation of 5-methyltetrahydrofolate [11]. From
thesestudies,wecanassessthatethanolimpairsFL-MTXand
also its analogues, 5M and folic acid.
Chronic ethanol decreases endothelin-stimulated glu-
cose uptake in rat adipocytes [24]. Folate supplementation
improves endothelial function while in hyperhomocysteine-
mia [25]. These reports provide ample evidences regarding
endothelin function in FL-MTX transport. In order to eval-
uate the mechanism of ethanol-mediated FL-MTX uptake
studies, we used ET-B receptor antagonist (RES-701-1) or
PKC-selective inhibitor (BIM). The experiments on these
compounds show that ethanol may act via ET and ET in
turn may act via ET-B receptor and PKC signaling pathway
toimpairFL-MTXuptake.RenalETproductionisassociated
with a number of renal diseases and also with the action
of chemical toxicants [15]. Urinary ET-1 excretion increases
in renal failure from a variety of causes including radioAdvances in Pharmacological Sciences 5
contrast nephropathy and chemical therapy [26, 27]. The
toxic chemicals normally alter tubular function through ET
receptor [28]. The eﬀect of ethanol on FL-MTX transport
was abolished by adding ET-B receptor antagonist, RES-701-
1, or by adding PKC-selective inhibitor-BIM to the HPT
cells in 24 well plates in this study. Endothelin-B exerts its
eﬀect through Protein Kinase C [29, 30]. Hamid and Kaur
[31] revealed the role of PKC in intestinal folate transport
during alcohol conditions. Although blocking any of the
steps in the ET-ETB-NOS-NO-PKC pathway eliminates the
eﬀect of certain chemicals or nephrotoxicants on transport
pathway,justblockingETBreceptor,theﬁrststepinsignaling
is suﬃcient [15]. We used both ET-B receptor antagonist and
PKC inhibitor in diﬀerent times in order to limit the eﬀect of
ethanol on transport.
By using the folate analogue, FL-MTX, we developed
this method to evaluate the mechanism of ethanol mediated
FL-MTX transport. Our uptake methods by using confocal
microscope and ﬂuoroskan microplate reader showed that
ethanol-impaired FL-MTX uptake was mediated through
endothelin signaling. Our HPT cells in 24 well plates
provided a good model for this study. On the therapeutic
point of view, ET receptor antagonists may prevent ethanol
impaired FL-MTX or folate uptake.
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